duroquinol has been researched along with hydroquinone in 1 studies
| Studies (duroquinol) | Trials (duroquinol) | Recent Studies (post-2010) (duroquinol) | Studies (hydroquinone) | Trials (hydroquinone) | Recent Studies (post-2010) (hydroquinone) |
|---|---|---|---|---|---|
| 49 | 0 | 6 | 1,888 | 111 | 709 |
| Protein | Taxonomy | duroquinol (IC50) | hydroquinone (IC50) |
|---|---|---|---|
| Polyphenol oxidase 2 | Agaricus bisporus | 9.81 | |
| large T antigen | Betapolyomavirus macacae | 7.76 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araya-Maturana, R; Ferreira, J; Jaña-Prado, F; Lapier, M; Martínez-Cifuentes, M; Maya, JD; Parra, E; Pavani, M; Pessoa-Mahana, H; Urra, FA | 1 |
1 other study(ies) available for duroquinol and hydroquinone
| Article | Year |
|---|---|
An ortho-carbonyl substituted hydroquinone derivative is an anticancer agent that acts by inhibiting mitochondrial bioenergetics and by inducing G₂/M-phase arrest in mammary adenocarcinoma TA3.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Energy Metabolism; G2 Phase Cell Cycle Checkpoints; Hydroquinones; Male; Mammary Neoplasms, Animal; Mice; Mitochondria | 2013 |